Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma

被引：5

作者：

Claveau, Jean-Sebastien ^{[1
]}

Savary Belanger, Sophie ^{[1
]}

Ahmad, Imran ^{[1
]}

Delisle, Jean-Sebastien ^{[1
]}

De Guire, Vincent ^{[2
]}

Roy, Jean ^{[1
]}

LeBlanc, Richard ^{[1
]}

机构：

[1] Univ Montreal, Maisonneuve Rosemont Hosp, Dept Med, Div Hematol Oncol & Transplantat, Montreal, PQ, Canada

[2] Univ Montreal, Dept Biochem, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada

来源：

BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期

关键词：

MULTIPLE-MYELOMA; CRITERIA;

D O I：

10.1038/s41408-021-00600-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 15 条

[1] Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ Ratios [J].

Bradwell, Arthur R. ;

Harding, Stephen J. ;

Fourrier, Nicolas J. ;

Wallis, Gregg L. F. ;

Drayson, Mark T. ;

Carr-Smith, Hugh D. ;

Mead, Graham P. .

CLINICAL CHEMISTRY, 2009, 55 (09) :1646-1655

[2]

Das M, 2005, BLOOD, V106, p355B

[3] International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders [J].

Dispenzieri, A. ;

Kyle, R. ;

Merlini, G. ;

Miguel, J. S. ;

Ludwig, H. ;

Hajek, R. ;

Palumbo, A. ;

Jagannath, S. ;

Blade, J. ;

Lonial, S. ;

Dimopoulos, M. ;

Comenzo, R. ;

Einsele, H. ;

Barlogie, B. ;

Anderson, K. ;

Gertz, M. ;

Harousseau, J. L. ;

Attal, M. ;

Tosi, P. ;

Sonneveld, P. ;

Boccadoro, M. ;

Morgan, G. ;

Richardson, P. ;

Sezer, O. ;

Mateos, M. V. ;

Cavo, M. ;

Joshua, D. ;

Turesson, I. ;

Chen, W. ;

Shimizu, K. ;

Powles, R. ;

Rajkumar, S. V. ;

Durie, B. G. M. .

LEUKEMIA, 2009, 23 (02) :215-224

[4] Appraisal of immunoglobulin free light chain as a marker of response [J].

Dispenzieri, Angela ;

Zhang, Lijun ;

Katzmann, Jerry A. ;

Snyder, Melissa ;

Blood, Emily ;

DeGoey, Roberta ;

Henderson, Kimberly ;

Kyle, Robert A. ;

Oken, Martin M. ;

Bradwell, Arthur R. ;

Greipp, Philip R. .

BLOOD, 2008, 111 (10) :4908-4915

[5] International uniform response criteria for multiple myeloma [J].

Durie, B. G. M. ;

Harousseau, J-L ;

Miguel, J. S. ;

Blade, J. ;

Barlogie, B. ;

Anderson, K. ;

Gertz, M. ;

Dimopoulos, M. ;

Westin, J. ;

Sonneveld, P. ;

Ludwig, H. ;

Gahrton, G. ;

Beksac, M. ;

Crowley, J. ;

Belch, A. ;

Boccadaro, M. ;

Turesson, I. ;

Joshua, D. ;

Vesole, D. ;

Kyle, R. ;

Alexanian, R. ;

Tricot, G. ;

Attal, M. ;

Merlini, G. ;

Powles, R. ;

Richardson, P. ;

Shimizu, K. ;

Tosi, P. ;

Morgan, G. ;

Rajkumar, S. V. .

LEUKEMIA, 2006, 20 (09) :1467-1473

[6] Serial measurement of free light chain detects poor response to therapy early in three patients with multiple myeloma who have measurable M-proteins [J].

Fuchida, Shin-ichi ;

Okano, Akira ;

Hatsuse, Mayumi ;

Murakami, Satoshi ;

Haruyama, Harue ;

Itoh, Saori ;

Shimazaki, Chihiro .

INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) :664-668

[7] Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR [J].

Hansen, Charlotte T. ;

Pedersen, Per T. ;

Nielsen, Lars C. ;

Abildgaard, Niels .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 (05) :407-413

[8] Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV) [J].

Holzhey, Tanja ;

Poenisch, Wolfram ;

Wang, Song-Yau ;

Holzvogt, Madlen ;

Holzvogt, Bruno ;

Andrea, Marc ;

Zehrfeld, Thomas ;

Hammerschmidt, Doreen ;

Hoffmann, Franz Albert ;

Becker, Cornelia ;

Schwarzer, Andreas ;

Schwarz, Maik ;

Schoenfelder-Fricke, Uta ;

Edelmann, Thomas ;

Braunert, Leanthe ;

Franke, Georg-Nikolaus ;

Jentzsch, Madlen ;

Schwind, Sebastian ;

Bill, Markus ;

Grimm, Juliane ;

Remane, Yvonne ;

Platzbecker, Uwe ;

Scholz, Markus .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (08) :2349-2359

[9] International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma [J].

Kumar, Shaji ;

Paiva, Bruno ;

Anderson, Kenneth C. ;

Durie, Brian ;

Landgren, Ola ;

Moreau, Philippe ;

Munshi, Nikhil ;

Lonial, Sagar ;

Blade, Joan ;

Mateos, Maria-Victoria ;

Dimopoulos, Meletios ;

Kastritis, Efstathios ;

Boccadoro, Mario ;

Orlowski, Robert ;

Goldschmidt, Hartmut ;

Spencer, Andrew ;

Hou, Jian ;

Chng, Wee Joo ;

Usmani, Saad Z. ;

Zamagni, Elena ;

Shimizu, Kazuyuki ;

Jagannath, Sundar ;

Johnsen, Hans E. ;

Terpos, Evangelos ;

Reiman, Anthony ;

Kyle, Robert A. ;

Sonneveld, Pieter ;

Richardson, Paul G. ;

McCarthy, Philip ;

Ludwig, Heinz ;

Chen, Wenming ;

Cavo, Michele ;

Harousseau, Jean-Luc ;

Lentzsch, Suzanne ;

Hillengass, Jens ;

Palumbo, Antonio ;

Orfao, Alberto ;

Rajkumar, S. Vincent ;

Miguel, Jesus San ;

Avet-Loiseau, Herve .

LANCET ONCOLOGY, 2016, 17 (08) :E328-E346

[10] Review of 1027 patients with newly diagnosed multiple myeloma [J].

Kyle, RA ;

Gertz, MA ;

Witzig, TE ;

Lust, JA ;

Lacy, MQ ;

Dispenzieri, A ;

Fonseca, R ;

Rajkumar, SV ;

Offord, JR ;

Larson, DR ;

Plevak, ME ;

Therneau, TM ;

Greipp, PR .

MAYO CLINIC PROCEEDINGS, 2003, 78 (01) :21-33

← 1 2 →